Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01251302 · ClinicalTrials.gov registry record
Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 171
- Enrollment target
NCT01251302 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 171 participants.
The verdict
NCT01251302 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
Study Summary
To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms.
Interventions
- DIAGNOSTIC_TEST Corus CAD (ASGES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01251302
The ClinicalTrials.gov registry entry for NCT01251302 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioDx, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Corus CAD (ASGES) is the first listed.
NCT01251302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01251302 about?
NCT01251302 is a clinical study titled "Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern". To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms.
What is the current status of trial NCT01251302?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2010-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01251302?
The interventions under investigation include: Corus CAD (ASGES) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01251302?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.